Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Some people come weekly during illness, others schedule monthly maintenance treatments, and athletes may visit before and after competitions
ROS prioritizes patient education, transparency, and the ethical application of peptide therapy, offering treatments backed by scientific research and clinical experience
Glutathione, often hailed as the "master antioxidant," plays a crucial role in maintaining optimal health and radiant beauty
Most common adverse events at all doses: Nausea (3355%, dose-related) Vomiting (1335%) Decreased appetite (1528%) Constipation or diarrhea (1020%) Injection-site reaction (510%) Dose-related dysesthesia signal: The TRIUMPH-4 trial identified a dose-related dysesthesia (nerve-tingling, paresthesia) signal: This is the most-flagged trial-level safety signal for retatrutide and the reason community doses cluster at 2-4 mg/week well below where the dysesthesia signal becomes prominent
Red flags include vague descriptions (high-grade), lack of analytical reports, no contact information, or claims about health benefits that sound too good to be true
